NVIV - InVivo Therapeutics beats by $6.89 April, 01 2019 08:18 AM InVivo Therapeutics Holdings Corp. InVivo Therapeutics (NASDAQ:NVIV): FY Non-GAAP EPS of -$2.25; GAAP EPS of -$4.69 beats by $6.89.Cash and cash equivalents of $16.66MPress ReleaseMore news on: InVivo Therapeutics Holdings Corp., Earnings news and commentary, Healthcare stocks news, ,